Fabrication of BMP-2-peptide-Deferoxamine- and QK-peptide-functionalized nanoscaffolds and their application for bone defect treatment

J Tissue Eng Regen Med. 2022 Dec;16(12):1223-1237. doi: 10.1002/term.3364. Epub 2022 Nov 8.

Abstract

The microenvironment in the healing process of large bone defects requires suitable conditions to promote osteogenesis and angiogenesis. Coaxial electrospinning is a mature method in bone tissue engineering (BTE) and allows functional modification. Appropriate modification methods can be used to improve the bioactivity of scaffolds for BTE. In this study, coaxial electrospinning with QK peptide (a Vascular endothelial growth factor mimetic peptide) and BMP-2 peptide-DFO (BD) was performed to produce double-modified PQBD scaffolds with vascularizing and osteogenic features. The morphology of coaxially electrospun scaffolds was verified by scanning electron microscopy (SEM) and transmission electron microscopy. Laser scanning confocal microscopy and Fourier transform infrared spectroscopy confirmed that BD covalently bound to the surface of the P and PQ scaffolds. In vitro, the PQBD scaffold promoted the adhesion and proliferation of bone marrow stromal cells (BMSCs). Both QK peptide and BD showed sustainable release and preservation of biological activity, enhancing the osteogenic differentiation of BMSCs and the migration of human umbilical vein endothelial cells and promoting angiogenesis. The combined ability of these factors to promote osteogenesis and angiogenesis is superior to that of each alone. In vivo, the PQBD scaffold was implanted into the bone defect, and after 8 weeks, the defect area was almost completely covered by new bone tissue. Histology showed more mature bone tissue and more blood vessels. PQBD scaffolds promote both angiogenesis and osteogenesis, offering a promising approach to enhance bone regeneration in the treatment of large bone defects.

Keywords: tendon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Regeneration
  • Cell Differentiation
  • Deferoxamine*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Osteogenesis*
  • Peptides / chemistry
  • Peptides / pharmacology
  • Tissue Engineering / methods
  • Tissue Scaffolds / chemistry
  • Vascular Endothelial Growth Factor A

Substances

  • Deferoxamine
  • Vascular Endothelial Growth Factor A
  • Peptides